Speaker

Last Update: June 2026

Benoît Chassaing
Institut Pasteur, France

Benoît Chassaing and his team work in the field of Mucosal Microbiology. They are focusing on how genetic and environmental factors impact the intestinal microbiota in a way that can drive chronic diseases – crucial research for developing microbiome-based personalized nutrition and medicine.

Eran Elinav
Weizmann Institute of Science Rehovot, Israel

In Eran Elinav’s lab, he and his team study interactions between mammal hosts and their microbiomes, uncovering their effects on health and disease. They devise microbiome-based personalized medicine using experimental biology, human trials and big data analyses.

Neha Garg
Georgia Institute of Technology, United States

Neha Garg’s lab focuses on the interaction between eukaryotes and the microbiomes that they host, wanting to understand how these interactions affect health. They aim to delineate specific molecules that influence microbial involvement in disease trigger responses. These natural products are to be used in the development of therapeutics.

Kiran Patil
University of Cambridge, United Kingdom

Kiran Patil’s research program is set out to explore the interaction between the human microbiome and various drugs as well as xenobiotics humans are exposed to. Using computational and experimental approaches, Patil and his team work on gaining insights into microbiome-mediated toxicity.

Bertrand Routy
Université de Montréal, Canada

Bertrand Routy works in hematology and oncology. He directs the Laboratory of Immunotherapy and Oncomicrobiome at Université de Montréal where he and his team aim to predict clinical resistance/response to anti-PD1/PD-L1/PD-L2 blockade in cancer using a gut microbial fingerprint based on metagenomics profiling of patients’ stools.

Nina van Sorge
Amsterdam UMC, The Netherlands

Nina van Sorge’s group works to clarify the molecular pathogenesis of bacterial infections with a specific focus on human pathogens, elucidating how their cell wall polysaccharides impact recognition by receptors and antibodies. Her overall goal is to contribute to combatting infections by pathogens for which there are no vaccines yet.

Conference Chairs

Heike Brötz-Oesterhelt
Ruth Ley
Hannes Link
Lukas Mager
Lisa Maier
Andreas Peschel
Christoph Stein-Thoeringer
Alexander Weber
Nadine Ziemert